Environmental Engineering Reference
In-Depth Information
23. Guan R, Ma J, Wu Y, Lu F, Xiao C, Jiang H, Kang T (2012) Development and character-
ization of lactoferrin nanoliposome: cellular uptake and stability. Nanoscale Res Lett 7
(1):679. doi:
10.1186/1556-276X-7-679
24. Elmeshad AN, Mortazavi SM, Mozafari MR (2014) Formulation and characterization of
nanoliposomal 5-fluorouracil for cancer nanotherapy. J Liposome Res 24(1):1-9. doi:
10.
25. Xu QH, Shi JY, Zhang J, Sun YF, Chang AH, Zhao YM, Cai WJ, Liu D, Zhou CC, Fan LH,
Su B (2014) Comparison of tumor neovasculature-targeted paramagnetic nanoliposomes for
MRI in mice xenograft models. Clin Transl Oncol. doi:
10.1007/s12094-013-1091-4
26. Tiantian Y, Wenji Z, Mingshuang S, Rui Y, Shuangshuang S, Yuling M, Jianhua Y,
Xinggang Y, Shujun W, Weisan P (2014) Study on intralymphatic-targeted hyaluronic
acid-modified nanoliposome: influence of formulation factors on the lymphatic targeting.
Int J Pharm 471(1-2):245-257. doi:
10.1016/j.ijpharm.2014.05.027
27. Zou LQ, Liu W, Liu WL, Liang RH, Li T, Liu CM, Cao YL, Niu J, Liu Z (2014)
Characterization and bioavailability of tea polyphenol nanoliposome prepared by combining
an ethanol injection method with dynamic high-pressure microfluidization. J Agric Food
Chem 62(4):934-941. doi:
10.1021/jf402886s
28. Fox CB, Sivananthan SJ, Duthie MS, Vergara J, Guderian JA, Moon E, Coblentz D, Reed SG,
Carter D (2014) A nanoliposome delivery system to synergistically trigger TLR4 AND
TLR7. J Nanobiotechnol 12(1):17. doi:
10.1186/1477-3155-12-17
29. Hasan M, Belhaj N, Benachour H, Barberi-Heyob M, Kahn CJ, Jabbari E, Linder M, Arab-
Tehrany E (2014) Liposome encapsulation of curcumin: physico-chemical characterizations
and effects on MCF7 cancer cell proliferation. Int J Pharm 461(1-2):519-528. doi:
10.1016/j.
30. Ghosh S, Pal S, Prusty S, Girish KVS (2012) Curcumin and cancer: recent developments. J
Res Biol 3:251-272
31. Bouarab L, Maherani B, Kheirolomoom A, Hasan M, Aliakbarian B, Linder M, Arab-
Tehrany E (2014) Influence of lecithin-lipid composition on physico-chemical properties of
nanoliposomes loaded with a hydrophobic molecule. Colloids Surf B Biointerfaces
115:197-204. doi:
10.1016/j.colsurfb.2013.11.034
32. Rodr´guez-Gasc´n A, del Pozo-Rodr´guez A, Solin´sM
´
(2014) Development of nucleic
acid vaccines: use of self-amplifying RNA in lipid nanoparticles. Int J Nanomedicine
9:1833-1843. doi:
10.2147/IJN.S39810
33. Jung S, Patzelt A, Otberg N, Thiede G, Sterry W, Lademann J (2009) Strategy of topical
vaccination with nanoparticles. J Biomed Opt 14(2):021001. doi:
10.1117/1.3080714
34. Firouzmand H, Badiee A, Khamesipour A, Heravi Shargh V, Alavizadeh SH, Abbasi A,
Jaafari MR (2013) Induction of protection against leishmaniasis in susceptible BALB/c mice
using simple DOTAP cationic nanoliposomes containing soluble Leishmania antigen (SLA).
Acta Trop 128(3):528-535. doi:
10.1016/j.actatropica.2013.07.021
35. Rangger C, Helbok A, Sosabowski J, Kremser C, Koehler G, Prassl R, Andreae F, Virgolini
IJ, von Guggenberg E, Decristoforo C (2013) Tumor targeting and imaging with dual-peptide
conjugated multifunctional
liposomal nanoparticles. Int J Nanomedicine 8:4659-4671.
doi:
10.2147/IJN.S51927
36. Accardo A, Aloj L, Aurilio M, Morelli G, Tesauro D (2014) Receptor binding peptides for
target-selective delivery of nanoparticles encapsulated drugs.
Int
J Nanomedicine
9:1537-1557. doi:
10.2147/IJN.S53593
37. Ghosh S, Saha S, Sur A (in press) Polymeric nanoparticles: application in cancer manage-
ment. Encyclopedia of biomedical polymers and polymeric biomaterials. Taylor & Francis
38. Lo YL, Liu Y (2014) Reversing multidrug resistance in Caco-2 by silencing MDR1, MRP1,
MRP2, and BCL-2/BCL-xL using liposomal antisense oligonucleotides. PLoS One Mar
17;9(3):e90180.doi: doi:
10.1371/journal.pone.0090180
